Progress with YAP/TAZ-TEAD inhibitors: a patent review (2018-present)
{{output}}
Introduction: The Hippo pathway represents a new opportunity for the treatment of cancer. Overexpression of Yes-associated protein (YAP) or transcriptional coactivator with PDZ-binding motif (TAZ) or TEAD has been demonstrated in... ...
